The Future Role of the United States in Global Health Emphasis on Cardiovascular Disease
The Future Role of the United States in Global Health Emphasis on Cardiovascular Disease
复制标题
DOI：
10.1016/j.jacc.2017.11.009
复制
发表时间：
2017-12-26
影响因子：
24
通讯作者：
Dzau, Victor
中科院分区：
文献类型：
--
作者：
Fuster, Valentin;Frazer, Jendayi;Dzau, Victor
美国的全球卫生投资主要集中在结核病、疟疾和人类免疫缺陷病毒/获得性免疫缺陷综合征等传染病的检测、治疗和根除上，取得了显著成果。虽然应保持和扩大努力，为慢性传染病提供持续治疗，但迫切需要应对非传染性疾病的挑战，因为非传染性疾病是全球最大的疾病负担。美国国家科学院、工程院和医学院的一个委员会提出了14项建议，要求继续致力于消除传染病，并加强对心血管疾病等慢性病的重视。这些措施包括改善早期发现和治疗，减少疾病风险因素，转变全球卫生基础设施以包括心血管疾病的管理，发展全球合作伙伴和公私合营企业以应对基础设施和资金挑战，简化医疗产品开发和供应，提高研发能力，以及解决全球政治和机构领导力的差距以应对不断变化的挑战。(c)2017年由爱思唯尔代表美国心脏病学院基金会发布。
U.S. global health investment has focused on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and human immunodeficiency virus/acquired immunodeficiency syndrome, with significant results. Although efforts should be maintained and expanded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the challenge of noncommunicable diseases, which constitute the highest burden of diseases globally. A Committee of the National Academies of Sciences, Engineering, and Medicine has made 14 recommendations that require ongoing commitments to eradication of infectious disease and increase the emphasis on chronic diseases such as cardiovascular disease. These include improving early detection and treatment, mitigating disease risk factors, shifting global health infrastructure to include management of cardiovascular disease, developing global partners and private-public ventures to meet infrastructure and funding challenges, streamlining medical product development and supply, increasing research and development capacity, and addressing gaps in global political and institutional leadership to meet the shifting challenge. (c) 2017 Published by Elsevier on behalf of the American College of Cardiology Foundation.